Literature DB >> 21730069

STAT3 protein promotes T-cell survival and inhibits interleukin-2 production through up-regulation of Class O Forkhead transcription factors.

Hyun-Mee Oh1, Cheng-Rong Yu, Nady Golestaneh, Ahjoku Amadi-Obi, Yun Sang Lee, Amarachi Eseonu, Rashid M Mahdi, Charles E Egwuagu.   

Abstract

Much is known about the role of STAT3 in regulating differentiation of interleukin-17-producing Th17 cells, but its function in other lymphocyte subsets is not well understood. In this report, we reveal wide-ranging functions of STAT3 in T-cells and provide evidence that STAT3 is convergence point for mechanisms that regulate lymphocyte quiescence and those controlling T-cell activation and survival. We show here that STAT3 inhibits T-lymphocyte proliferation by up-regulating the expression of Class-O Forkhead transcription factors, which play essential roles in maintaining T-cells in quiescent state. We further show that STAT3 binds directly to FoxO1 or FoxO3a promoter and that STAT3-deficiency resulted in down-regulation of the expression of FoxO1, FoxO3a and FoxO-target genes (IκB and p27Kip1). Compared with wild-type T-cells, STAT3-deficient T-cells produced more IL-2, due in part, to marked decrease in IκB-mediated sequestration of NF-κB in the cytoplasm and resultant enhancement of NF-κB activation. However, the high level of IL-2 production by STAT3-deficient T-cells was partially restored to normal levels by overexpressing FoxO1. It is notable that their exaggerated increase in IL-2 production rendered STAT3-deficient lymphocytes more susceptible to activation-induced cell death, suggesting that STAT3 might protect T-cells from apoptosis by limiting their production of IL-2 through up-regulation of FoxO1/FoxO3a expression. Moreover, we found that STAT3 enhanced survival of activated T-cells by up-regulating OX-40 and Bcl-2 while down-regulating FasL and Bad expression, suggesting that similar to role of FoxOs in regulating the lifespan of worms, STAT3 and FoxO pathways converge to regulate lifespan of T-lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21730069      PMCID: PMC3162449          DOI: 10.1074/jbc.M111.253500

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Regulation of NF-kappaB, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a.

Authors:  Ling Lin; Jonathan D Hron; Stanford L Peng
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

2.  Inducible nuclear expression of newly synthesized I kappa B alpha negatively regulates DNA-binding and transcriptional activities of NF-kappa B.

Authors:  F Arenzana-Seisdedos; J Thompson; M S Rodriguez; F Bachelerie; D Thomas; R T Hay
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

3.  DNA binding specificity of different STAT proteins. Comparison of in vitro specificity with natural target sites.

Authors:  G B Ehret; P Reichenbach; U Schindler; C M Horvath; S Fritz; M Nabholz; P Bucher
Journal:  J Biol Chem       Date:  2000-10-26       Impact factor: 5.157

4.  The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2.

Authors:  Marie Stahl; Pascale F Dijkers; Geert J P L Kops; Susanne M A Lens; Paul J Coffer; Boudewijn M T Burgering; René H Medema
Journal:  J Immunol       Date:  2002-05-15       Impact factor: 5.422

5.  Suppressors of cytokine signaling proteins are differentially expressed in Th1 and Th2 cells: implications for Th cell lineage commitment and maintenance.

Authors:  Charles E Egwuagu; Cheng-Rong Yu; Meifen Zhang; Rashid M Mahdi; Stephen J Kim; Igal Gery
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

6.  Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis.

Authors:  Lydia Durant; Wendy T Watford; Haydeé L Ramos; Arian Laurence; Golnaz Vahedi; Lai Wei; Hayato Takahashi; Hong-Wei Sun; Yuka Kanno; Fiona Powrie; John J O'Shea
Journal:  Immunity       Date:  2010-05-20       Impact factor: 31.745

7.  Cell proliferation and STAT6 pathways are negatively regulated in T cells by STAT1 and suppressors of cytokine signaling.

Authors:  Cheng-Rong Yu; Rashid M Mahdi; Samuel Ebong; Barbara P Vistica; Jun Chen; Yonghong Guo; Igal Gery; Charles E Egwuagu
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

8.  Multiple elements regulate nuclear/cytoplasmic shuttling of FOXO1: characterization of phosphorylation- and 14-3-3-dependent and -independent mechanisms.

Authors:  Xiangshan Zhao; Lixia Gan; Haiyun Pan; Donghui Kan; Michael Majeski; Stephen A Adam; Terry G Unterman
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

Review 9.  Overview of interleukin-2 function, production and clinical applications.

Authors:  Sarah L Gaffen; Kathleen D Liu
Journal:  Cytokine       Date:  2004-11-07       Impact factor: 3.861

10.  Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B.

Authors:  T Henkel; T Machleidt; I Alkalay; M Krönke; Y Ben-Neriah; P A Baeuerle
Journal:  Nature       Date:  1993-09-09       Impact factor: 49.962

View more
  47 in total

Review 1.  FOXO3: A Major Gene for Human Longevity--A Mini-Review.

Authors:  Brian J Morris; Donald Craig Willcox; Timothy A Donlon; Bradley J Willcox
Journal:  Gerontology       Date:  2015-03-28       Impact factor: 5.140

Review 2.  Dynamic aberrant NF-κB spurs tumorigenesis: a new model encompassing the microenvironment.

Authors:  Spiros A Vlahopoulos; Osman Cen; Nina Hengen; James Agan; Maria Moschovi; Elena Critselis; Maria Adamaki; Flora Bacopoulou; John A Copland; Istvan Boldogh; Michael Karin; George P Chrousos
Journal:  Cytokine Growth Factor Rev       Date:  2015-06-20       Impact factor: 7.638

3.  CCR8 blockade primes anti-tumor immunity through intratumoral regulatory T cells destabilization in muscle-invasive bladder cancer.

Authors:  Tao Wang; Quan Zhou; Han Zeng; Hongyu Zhang; Zhaopei Liu; Jialiang Shao; Zewei Wang; Ying Xiong; Jiajun Wang; Qi Bai; Yu Xia; Yiwei Wang; Li Liu; Yu Zhu; Le Xu; Bo Dai; Jianming Guo; Yuan Chang; Xiang Wang; Jiejie Xu
Journal:  Cancer Immunol Immunother       Date:  2020-05-04       Impact factor: 6.968

4.  Association Analysis of FOXO3 Longevity Variants With Blood Pressure and Essential Hypertension.

Authors:  Brian J Morris; Randi Chen; Timothy A Donlon; Daniel S Evans; Gregory J Tranah; Neeta Parimi; Georg B Ehret; Christopher Newton-Cheh; Todd Seto; D Craig Willcox; Kamal H Masaki; Kei Kamide; Hirochika Ryuno; Ryosuke Oguro; Chikako Nakama; Mai Kabayama; Koichi Yamamoto; Ken Sugimoto; Kazunori Ikebe; Yukie Masui; Yasumichi Arai; Tatsuro Ishizaki; Yasuyuki Gondo; Hiromi Rakugi; Bradley J Willcox
Journal:  Am J Hypertens       Date:  2016-11-01       Impact factor: 2.689

5.  Lack of Ikaros cripples expression of Foxo1 and its targets in naive T cells.

Authors:  Parul Agnihotri; Nicholas M Robertson; Sarah E Umetsu; Ksenia Arakcheeva; Susan Winandy
Journal:  Immunology       Date:  2017-08-23       Impact factor: 7.397

Review 6.  Mitochondrial and postmitochondrial survival signaling in cancer.

Authors:  Neelu Yadav; Dhyan Chandra
Journal:  Mitochondrion       Date:  2013-12-10       Impact factor: 4.160

7.  Serotonin promotes the proliferation of serum-deprived hepatocellular carcinoma cells via upregulation of FOXO3a.

Authors:  Chao Liang; Wei Chen; Xiao Zhi; Tao Ma; Xuefeng Xia; Hao Liu; Qi Zhang; Qida Hu; Yun Zhang; Xueli Bai; Tingbo Liang
Journal:  Mol Cancer       Date:  2013-02-19       Impact factor: 27.401

8.  Novel IL27p28/IL12p40 cytokine suppressed experimental autoimmune uveitis by inhibiting autoreactive Th1/Th17 cells and promoting expansion of regulatory T cells.

Authors:  Ren-Xi Wang; Cheng-Rong Yu; Rashid M Mahdi; Charles E Egwuagu
Journal:  J Biol Chem       Date:  2012-08-30       Impact factor: 5.157

9.  STAT3 Impairs STAT5 Activation in the Development of IL-9-Secreting T Cells.

Authors:  Matthew R Olson; Felipe Fortino Verdan; Matthew M Hufford; Alexander L Dent; Mark H Kaplan
Journal:  J Immunol       Date:  2016-03-14       Impact factor: 5.422

Review 10.  FOXO transcription factors throughout T cell biology.

Authors:  Stephen M Hedrick; Rodrigo Hess Michelini; Andrew L Doedens; Ananda W Goldrath; Erica L Stone
Journal:  Nat Rev Immunol       Date:  2012-09       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.